Officials and policymakers say direct-to-consumer drug advertising encourages patients to seek treatments they don’t need and raises heath care costs, but the true picture is more nuanced.
HekaBio K.K., (Headquarters: Chuo-ku, Tokyo) announces that the innovative solid tumor treatment device 'Alpha DaRT (Diffusing Alpha Radiation Therapy),' developed by Alpha Tau Medical Ltd.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results